For 25 years now the DAA has worked to support people living with HIV, while actively promoting HIV prevention and sexual health awareness in the general population.
As back to school season approaches, Pilot Corporation of America (Pilot Pen) is working diligently to help empower students to excel and to overcome their greatest challenges during the school year. Bullying and cyberbullying are at an all time high, with nearly 1 out of 4 U.S. students having been bullied. Pilot Pen’s ongoing partnership with the nation’s leading anti-bullying prevention organization, STOMP Out Bullying is designed to help “Erase Bullying For Good,” for the fourth consecutive year. The goal of this campaign is to raise awareness of this serious issue, helping to ensure that parents, educators and students are aware of the valuable resources available to those in need of support. As part of the effort, Pilot is donating 10 cents from every specially-marked package of FriXion Clicker erasable gel ink pens purchased during the back to school period, to support STOMP Out Bullying. Pilot is committed to donating $325,000 to the organization.
To view the multimedia release go to:
https://www.multivu.com/players/English/8342451-pilot-pen-stomp-out-erase-bullying-for-good/
May is Mental Health Awareness Month. Nine out of ten times when someone dies by suicide, they have a diagnosable mental health condition at the time of their death. However, mental health conditions are treatable, and most people who attempt suicide go on to live healthy productive lives.
Join the American Foundation for Suicide Prevention, the largest suicide prevention organization in the United States, in celebrating Mental Health Awareness Month. By drawing attention to the importance of mental health we hope to save lives and bring hope to those affected by suicide. Taking care of your mental health is the smart thing to do.
“Mental health is as important as physical health. It impacts the way we perceive, think, feel and behave in our daily lives,” said Dr. Christine Moutier, the chief medical officer of the American Foundation for Suicide Prevention. “To help us prevent suicide, there is a role for everyone, in every community. Don’t be afraid to have a caring conversation with someone if you notice troubling changes in their behavior. This conversation just might save their life.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7824851-afsp-suicide-mental-health-awareness-month/
See America, Allergan’s initiative to fight against preventable blindness in the United States, today unveiled a powerful video featuring award-winning actor and hip-hop artist Common, that urges Americans to “stand in the way of darkness”.
The video harnesses Common’s striking spoken word ability, calling on Americans to fight against vision loss and prioritize their vision. Common highlights the 61 million Americans at-risk of severe vision loss, and challenges us all to imagine a life without sight.
“I'm proud to join Allergan in the fight against preventable blindness,” said Common. “Sight is something that far too many of us take for granted. I hope our message resonates with people across the country, no matter what age or background.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8057551-common-joins-allergan-see-america-against-preventable-blindness/
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and the American Diabetes Association today revealed common challenges affecting the millions of Americans living with type 2 diabetes as part of the program America’s Diabetes Challenge: Get to Your Goals. Last year, award-winning artist Tim McGraw, renowned actress S. Epatha Merkerson and Chef Leticia Moreinos Schwartz called on patients and their loved ones to share their stories – from inspirational successes to daily struggles. Thousands of people from across the country responded, and revealed common challenges like eating healthy, exercising, sticking to a treatment plan and coping with the disease.
“Type 2 diabetes has affected my family, friends and fans, so I’ve learned it can be challenging to manage. It was great to hear from so many people, and I’m impressed by everyone’s dedication to their health,” said McGraw. “The stories we received shed an important light on the similar hardships people in the community face as they work toward achieving their blood sugar goals.”
To view the multimedia release go to:
https://www.multivu.com/players/English/7988751-merck-americas-diabetes-challenge-tim-mcgraw-s-epatha-merkerson-chef-leticia-moreinos-schwartz/
Vigilant Solutions, a global intelligence and analytics company serving law enforcement agencies, announced today BallisticSearch™, a new product providing law enforcement agencies with faster and more efficient cartridge case analysis, will be unveiled at the upcoming International Association of Chiefs of Police Conference, October 21st – 24th in Philadelphia. BallisticSearch includes portable image capture hardware, cartridge case capture software and ballistics comparison technology. The solution enables agencies to quickly compare evidence from crime scenes to help generate more investigative leads, and potentially identify more suspects and the firearms they use.
Developed using the company’s image analysis and technology expertise, BallisticSearch is designed to be the most efficient system available for analyzing ballistic evidence in both 2D and 3D format. BallisticSearch can process evidence in minutes, while other systems can take hours to process the same evidence. BallisticSearch’s faster analysis will have a huge impact on reducing backlogs. With faster comparisons and potential links established, agencies can generate strong investigative leads boosting their ability to solve crimes more quickly, in some cases right from the crime scene. This will help agencies establish a comprehensive ballistic collection program and ultimately reduce crime rates.
To view the multimedia release go to:
https://www.multivu.com/players/English/8134351-vigilant-solutions-ballisticsearch-faster-analysis/
Breast cancer now represents one in four of all cancers in women worldwide and touches lives every day. While experiences with the disease may vary, the desire to defeat breast cancer is universal. This year, in honor of a shared vision for a world without this disease, The Estée Lauder Companies’ Breast Cancer Awareness (BCA) Campaign celebrates the power of global solidarity by encouraging people around the world to “Take Action Together to Defeat Breast Cancer.” The 2016 BCA Campaign invites women, men and families to draw inspiration from one another and unite in action on BCAcampaign.com and social media, while supporting lifesaving breast cancer research.
Over the past two decades, The Estée Lauder Companies’ BCA Campaign, launched by the late Evelyn H. Lauder, co-creator of the Pink Ribbon and founder of the Breast Cancer Research Foundation® (BCRF), has been a leading voice for breast cancer awareness around the world, igniting a global movement that has helped save millions of lives and fund innovative breast cancer research. Today, The BCA Campaign is active in more than 70 countries and has raised more than $65 million to support global research, education and medical services, with more than $50 million funding 200 BCRF medical research grants worldwide over the past 22 years. These funds help accelerate critical research across wide-ranging areas such as tumor biology, heredity and ethnicity, lifestyle and prevention, treatment, survivorship and metastasis. Around the world, The BCA Campaign partners with more than 60 breast cancer organizations focused on breast cancer research, education and medical services. This year, The BCA Campaign is committed to raising $6 million in support of its mission to defeat breast cancer through education and medical research.
To view the multimedia release go to:
http://www.multivu.com/players/English/7935851-estee-lauder-bca-campaign-2016/
Results from two national surveys of patients receiving chemotherapy and pharmacists, conducted by the Hematology/Oncology Pharmacy Association (HOPA) in collaboration with Eisai Inc.,* found that 83% of patients receiving chemotherapy who have experienced chemotherapy-induced nausea and vomiting (CINV) believe it is a side effect with which they must live. Results also showed that 95% of cancer patients surveyed believe that CINV has, at some point, had an impact on their daily lives. These national surveys are part of the Time to Talk CINV™ campaign, which aims to increase awareness among patients and caregivers about CINV prevention and the importance of speaking with their pharmacist and full healthcare team about this often preventable side effect.
“The survey results underscore the confusion patients who are undergoing chemotherapy have about CINV and the need for them to understand that there are ways to manage their symptoms so that they do not have to needlessly suffer with CINV,” said Scott Soefje, PharmD, MBA, BCOP, President, Hematology/Oncology Pharmacy Association (HOPA) and Director of Pharmacy at the University Medical Center Brackenridge in Austin, TX. “It is imperative that patients discuss CINV prevention early in treatment and with all members of the health care team, including pharmacists.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7560331-time-to-talk-cinv/
Kelli Calabrese is a fitness, nutrition and lifestyle expert encouraging those who desire to be their best spirit, mind and body. Through her speaking, books and solutions, she inspires all to enjoy a fit energized body, sharp mind and joy-filled lifestyle. In addition to this, Kelli is business owner, international presenter, editor and mother of two preschoolers. Her passion for fitness began when Calabrese joined her first group fitness class at the age of thirteen.
For over 14 years Kelli owned and operated fitness centers and corporate fitness facilities for clients such as Calvin Klein, Beneficial Insurance and Nabisco. Kelli was the lead fitness expert for eDiets and eFitness for 3 years and continues to contribute articles to their e-zine. She has written over 100 articles or has been interviewed by companies such as WebMD, Prevention, Women's Day, Women's World, New York Times, New York Post, iVillage, iParenting, Shape, Martha Stewart, Beauty and Lace and more. Kelli has appeared on Fit week and had been interviewed on fitness and nutrition related topics for Comcast stations.
PDI, a leader in infection prevention products and solutions, announced the launch of its new EASY SCREEN™ CLEANING WIPE. This new product addresses the increasing use of touchscreen equipment in healthcare and the need for compatible cleaning products.
According to the Epocrates 2014 Mobile Trends Report, the presence of “digital omnivores,” a clinician regularly using digital devices including tablets, smartphones and computers, was 41 percent in 2014 and was predicted to increase to 74 percent in 2015. One of the biggest surges was expected to come from tablet usage, going from 45 percent in 2014 to 80 percent in 2015. Withstanding the apparent increase in touchscreen device usage in healthcare, a June 2015 study in the American Journal of Infection Control stated that proper protocols are lacking to address sensitive surfaces like touchscreen devices.
“Healthcare facilities are advancing everyday and it’s vital that we, as infection prevention leaders, are aware of the changes that are happening and able to adapt quickly. We created the EASY SCREEN™ CLEANING WIPE in response to the increasing usage of touchscreens and the need for a compatible product that wouldn’t damage the technology,” said PDI Senior Product Manager, Melanie Waddell.
To view the multimedia release go to:
http://www.multivu.com/players/English/7782451-pdi-easy-screen-cleaning-wipe/
The Ad Council’s I Am A Witness campaign is bringing together the top digital companies in the teen space for the second iteration of the award-winning and unprecedented effort aimed at transforming the “silent majority” of kids who witness bullying each day from passive bystanders into a united, empowered and active collective against bullying. The campaign is the first to create an anti-bullying emoji adopted by Unicode and natively available on nearly all smartphones across the world. There will be activations throughout the month of October to coincide with Bullying Prevention Month.
To view the multimedia release go to:
http://www.multivu.com/players/English/7933951-ad-council-i-am-a-witness-anti-bullying/
Global biotherapeutics leader CSL Behring today announced that results were published in the New England Journal of Medicine (NEJM) from the COMPACT study, a pivotal Phase III study evaluating the safety and efficacy of CSL830 (a novel, investigational, self-administered, subcutaneous C1-Esterase Inhibitor [C1-INH] Human replacement therapy) for the prevention of HAE attacks. The study met its primary efficacy endpoint, significantly reducing the time-normalized number of HAE attacks. In addition, the study met its secondary endpoints, including the responder rate (patients who had at least a 50% reduction in their attack rate) and the number of rescue medication uses. If approved by the FDA, CSL830 would be the first and only subcutaneous preventative therapy for HAE.
To view the multimedia release go to:
https://www.multivu.com/players/English/8056151-csl-behring-subcutaneous-c1-esterase-inhibitor-hae-patients/
